Pediatric toxic epidermal necrolysis treated successfully with infliximab

Keyphrases

• Infliximab 100%
• Pediatric 100%
• Toxic Epidermal Necrolysis 100%
• Symptom Onset 33%
• Clinical Features 33%
• Histopathological Features 33%
• 7-year-olds 33%
• Tumour Necrosis Factor Inhibitor (TNFi) 33%
• Mycoplasma Pneumoniae (M. pneumoniae) 33%
• Complete Resolution 33%
• Dry Eye 33%
• Progress Management 33%
• Blister Formation 33%
• Postinflammatory Hyperpigmentation 33%

Medicine and Dentistry

• Infliximab 100%
• Pediatrics 100%
• Toxic Epidermal Necrolysis 100%
• Symptom 33%
• Infection 33%
• Single Drug Dose 33%
• TNF Inhibitor 33%
• Sequela 33%
• Blister 33%
• Mycoplasma Pneumonia 33%
• Dry Eye 33%
• Postinflammatory Hyperpigmentation 33%